Corona virus: Why is India avoiding selling malaria medicines? - AB TAK NEWS

ADS1

Breaking

Post Top Ad 2

Post Top Ad3

subscribe my youtube channel techno chauhan

Tuesday, 7 April 2020

Corona virus: Why is India avoiding selling malaria medicines?

Corona virus: Why is India avoiding selling malaria medicines?


Hydroxychloroquine or HCOS. This drug used in malaria has now become the center of debate in India.

In his daily press conference on Tuesday evening, US President Donald Trump said that in response to the question related to this drug, if India does not sell this medicine to America then it can have 'consequences'.

Earlier, President Trump had described this drug as effective in the treatment of Kovid-19. However, his claim has not yet been confirmed by medical experts. The European Medicine Agency has said that this drug should not be used in the treatment of coronavirus, except in clinical trials.

Trump had also said in a statement earlier that he had asked Indian Prime Minister Narendra Modi to lift the ban on the export of hydroxychloroquine to the US.

But on Tuesday evening, when a journalist asked Trump, are you worried about Indian Prime Minister Narendra Modi banning hydroxychloroquine exports to America?

Trump said, "I have spoken to the Indian Prime Minister. We have had a good conversation. It would be nice if they send us anti-malarial medicines. If they do not, then it is obvious that the US will respond Can. "

At the same time, a few hours after Trump's statement, the Foreign Ministry of India has issued a statement saying that India has partially lifted the ban on export of this medicine, including this medicine.

The Ministry of External Affairs has also said in its statement that an unnecessary controversy is being created in a section of the media about medicines related to the corona virus.

In its statement, the Ministry of External Affairs has said that like any responsible government, our first priority is to ensure the availability of medicines for our population.

The Ministry of External Affairs says that a temporary ban on the export of hydroxychloroquine and other drugs was imposed under these efforts and after the analysis of all circumstances, the ban on the export of fourteen drugs has been partially lifted.

Meanwhile, the opposition has questioned the Indian government's decision to lift the ban on the export of this medicine.

Congress leader Rahul Gandhi has said, there is no reversal in friendship. India should help all countries in times of need, but life saving medicines should be made available in sufficient quantity to Indians first.

On the other hand, CPI (M) General Secretary Sitaram Yechury has said that Prime Minister Narendra Modi has come under pressure to reverse the US President.

While America has asked for these medicines from India, the companies of its country have banned the export of medical equipment or goods.

Hydroxychloroquine was invented during World War II. This drug is used in the treatment of malaria. Apart from this, it is also used for joint pain. According to the Lupus Center at Johns Hopkins University, USA, this drug reduces muscle and joint pain.

Many questions have arisen after India's ban on export of this drug and then removal of the ban after Trump's statement.

The biggest question is whether India has enough of this drug available for its population?

Ashok Madan, executive director of the Indian Drugs Manufacturers Association, says that India has enough of these drugs for its population.

He told the BBC, "If we talk according to the needs of today's date, then we have enough stock to meet the needs of India."

Madan explains, 'India needs about two million tablets every month. That is, about 24 million tablets in a year. At the same time, India can make 200 million tablets every year. That means our capacity is almost nine times more than required.

Says Madan, "Currently this drug is used in malaria and rheumotite arthritis. We are able to make it available in sufficient quantity, but how much the need of medicine will increase after Kovid-19 will also be known only after projection. But in today's time we can say that we are in a position to fulfill the domestic needs easily. ''

Madan says, "We also have some surplus of this medicine but the decision to export is for the government to take."

He said that the drug manufacturers have not received the notification from DGFT (Directorate General of Foreign Trade).

Madan says that the drug makers will work only according to the notification of DGFT. He says, "We will tell DGFT from which countries the orders have been received and how much money has been received, only then the export will be allowed."

India is one of the largest manufacturers of this medicine and mainly exports this medicine to African countries. Madan says that after the statement of US President Donald Trump, demand for this drug will increase in other countries as well. Due to the demand, its prices are also increasing.

He says, "When demand increases, prices also increase, it depends on the market."

Madan also says that the production capacity has also been affected due to the lockdown.

Meanwhile, this medicine can be acquired in India only on the advice of a doctor. Chemists will not be able to sell it over the counter.

However, its availability at drug stores in India is decreasing. The chemists we talked to said that this medicine is not available with them yet.

A chemist from Moradabad told that this medicine is now being sent directly to hospitals and chemists are not getting it.

Another chemist said that not only malaria medicines but other medicines are also not reaching the shops, the main reason for this is the supply chain being affected due to the lockdown.

No comments:

Post a comment

5